QPBE
TEVA icon

Quintet Private Bank (Europe)’s Teva Pharmaceuticals TEVA Stock Holding History

Quintet Private Bank (Europe)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200
Closed -$2.04K – 235
2023
Q3 		$2.04K Sell
200
-1
-0.5% -$9 ﹤0.01% 225
2023
Q2 		$1.5K Buy
201
+1
+0.5% +$8 ﹤0.01% 245
2023
Q1 		$1.77K Buy
+200
New +$1.98K ﹤0.01% 271
2022
Q2 		$1.5K Buy
+201
New +$1.75K ﹤0.01% 245

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Quintet Private Bank (Europe)'s TEVA Position: Q4 2023 in Review

Quintet Private Bank (Europe) sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 200 shares — an estimated $2.04K sold.

Quintet Private Bank (Europe) first reported a position in TEVA in Q2 2022 and held it in 4 quarters. The position peaked at $2.04K in Q3 2023. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Quintet Private Bank (Europe) reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Quintet Private Bank (Europe) sold 200 Teva Pharmaceuticals shares in Q4 2023, an estimated $2.04K.
  • Quintet Private Bank (Europe) first reported a position in Teva Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • Quintet Private Bank (Europe)'s Teva Pharmaceuticals position peaked at $2.04K in Q3 2023.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Quintet Private Bank (Europe)'s 13F filing for Q4 2023, filed 29 Feb 2024.